Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resident- and Facility-Level Correlates of Resident-Reported Quality of Life in Assisted Living Facilities in Minnesota.

Journal of the American Medical Directors Association·2026
Same author

Estimating a Physiological Lung Function Score and Biological Sex Using Pulmonary Function Tests and Machine Learning: Retrospective Study.

JMIR AI·2026
Same author

Proceedings From the Minnesota Learning Health Systems Symposium: The Role of Academic Partnership and (De)Implementation Science.

Mayo Clinic proceedings·2026
Same author

Anesthetic procedure outcomes after initial perioperative anaphylaxis: A retrospective multicenter US review.

The journal of allergy and clinical immunology. Global·2026
Same author

Microbial Detection in Community Acquired Pleural Space Infection Using the BioFire Joint Infection Panel and Individual PCR Assays.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Assisted living resident quality of life questionnaire: development and validation.

Journal of patient-reported outcomes·2026
Same journal

Prescription drug prior authorization: costs to pharmacies and physicians.

The American journal of managed care·2026
Same journal

Combined pharmacotherapy and psychotherapy impact on opioid use disorder treatment.

The American journal of managed care·2026
Same journal

The societal costs of food insecurity: implications for managed care strategies.

The American journal of managed care·2026
Same journal

Availability of hospital financial assistance documents in non-English languages.

The American journal of managed care·2026
Same journal

Real-world weight loss with injectable semaglutide vs dulaglutide for diabetes.

The American journal of managed care·2026
Same journal

Social needs screening and supplemental benefits in Medicare Advantage.

The American journal of managed care·2026
See all related articles

Related Experiment Video

Updated: Jul 2, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Flunking asthma? When HEDIS takes the ACT.

Kaiser G Lim1, Ashok M Patel, James M Naessens

  • 1Division of Pulmonary and Critical Care Medicine (E18), Mayo Clinic, Bldg E 18, 200 First St SW, Rochester, MN 55905, USA. lim.kaiser@mayo.edu

The American Journal of Managed Care
|August 12, 2008
PubMed
Summary
This summary is machine-generated.

Asthma control, measured by the Asthma Control Test (ACT), is a superior quality indicator for asthma care compared to medication adherence metrics. Achieving well-controlled asthma improves patient satisfaction and reduces healthcare use.

More Related Videos

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

Related Experiment Videos

Last Updated: Jul 2, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

Area of Science:

  • Pulmonary Medicine
  • Health Services Research
  • Quality Improvement

Background:

  • Asthma management quality is often assessed using process measures like medication adherence.
  • Patient-oriented outcomes provide a crucial perspective on the effectiveness of asthma care.

Purpose of the Study:

  • To compare patient-oriented asthma outcome measures with the Healthcare Effectiveness Data and Information Set (HEDIS) medication adherence measure.
  • To identify the most effective quality indicator for asthma care.

Main Methods:

  • A prospective mail survey was conducted among adult employees and dependents with asthma.
  • Medical and pharmacy claims data were analyzed for 12 months pre- and post-survey.
  • Outcome measures included the Asthma Control Test (ACT), workday loss, healthcare utilization, and patient satisfaction.

Main Results:

  • While 81% of participants had well-controlled asthma, 28% had persistent uncontrolled asthma.
  • Only 64.5% received appropriate controller medication.
  • Well-controlled asthma correlated with higher satisfaction, less workday loss, fewer prednisone bursts, and minimal unscheduled healthcare use.
  • HEDIS medication adherence was not significantly associated with improved patient-centered outcomes, except for reduced oral corticosteroid dispensings.

Conclusions:

  • Asthma control, particularly as measured by the ACT, emerged as the most valuable patient outcome quality indicator.
  • Current HEDIS asthma medication adherence measures did not demonstrate a strong association with better patient-oriented outcomes in this population.
  • Well-controlled asthma is linked to significant improvements in patient satisfaction, reduced healthcare utilization, and fewer missed workdays, supporting ACT as a superior performance measure.